Absence of polyneuropathy among workers previously diagnosed with solvent-induced toxic encephalopathy

Journal of Occupational and Environmental Medicine

Volumn 41, Issue 6, 1999, Pages 500-509

  Albers, James W ^a,b,c   Wald, John J ^a   Werner, Robert A ^a,b   Franzblau, Alfred ^b   Berent, Stanley ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOLVENT; TETRACHLOROETHYLENE; TRICHLOROETHANE; TRICHLOROETHYLENE;

ADULT; AGE; ARTICLE; BODY MASS; BRAIN DISEASE; CLINICAL ARTICLE; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; LONG TERM EXPOSURE; MALE; MOTOR NERVE CONDUCTION; OCCUPATIONAL EXPOSURE; POLYNEUROPATHY; RAILWAY EMPLOYEE; SENSORY NERVE CONDUCTION; SEX DIFFERENCE;

ADULT; AGED; BRAIN DISEASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYNEUROPATHIES; RAILROADS; SOLVENTS;

EID: 0033003383     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-199906000-00017     Document Type: Article

References (43)

1. Proceedings from the Workshop on Solvent Exposure Among Railroad Workers; organized by the Association of Occupational Environmental Clinics and sponsored by the National Institute for Occupational Safety and Health; November 7-8, 1996; Washington, DC.
2. Kuwabara S, Nakajima M, Tsuboi Y, Hirayama K. Multifocal conduction block in n-hexane neuropathy. Muscle Nerve. 1993;16:1416-1417.
3. Smith AG, Albers JW. n-Hexane neuropathy due to rubber cement sniffing. Muscle Nerve. 1997;20:1445-1450.
4. Chang CM, Yu CW, Fong KY, et al. n-Hexane neuropathy in offset printers. J Neurol Neurosurg Psychiatry. 1993;56: 538-542.
5. Scelsi R, Poggi P, Fera L, Gonella G. Industrial neuropathy due to n-hexane: clinical and morphological findings in three cases. Clin Toxicol. 1981;18:1387-1393.
6. Herskowitz A, Ishii N, Schaumburg HH. n-Hexane neuropathy. a syndrome occurring as a result of industrial exposure. N Engl J Med. 1971;285:82-85.
7. Paulson GW, Waylonis GW. Polyneuropathy due to n-hexane. Arch Intern Med. 1976;136:880-882.
8. Iida M. Neurophysiological studies in n-hexane polyneuropathy in the sandal factory. Electroencephalogr Clin Neurophysiol. 1982;36(suppl):671-681.
9. Spencer PS, Schaumburg HH, Raleigh RL, Terhaar CJ. Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone. Arch Neurol. 1975;32:219-222.
10. Spencer PS, Schaumburg HH. Organic solvent neurotoxicity: facts and research needs. Scand J Work Environ Health. 1985;11(suppl 1):53-60.
11. Maizlish NA, Fine LJ, Albers JW, Whitehead L, Langolf GD. A neurological evaluation of workers exposed to mixtures of organic solvents. Br J Ind Med. 1987;44:14-25.
12. Bleecker ML, Bolla KI, Agnew J, Schwartz BS. Dose-related subclinical neurobehavioral effects of chronic exposure to low levels of organic solvents. Am J Ind Med. 1991;19:715-728.
13. Baker EL, Fine LJ. Solvent neurotoxicity: the current evidence. J Occup Med. 1986;28:126-129.
14. Seppalainen AM. Neurotoxicity of organic solvents in occupational exposure. Scand J Work Environ Health. 1986; 11(suppl):61-64.
15. Baker EL. A review of recent research on health effects of human occupational exposure to organic solvents: a critical review. J Occup Med. 1994;36:1079-1092.
16. Seppalainen AM, Antti-Poika M. Time course of electrophysiological findings for patients with solvent poisoning: a descriptive study. Scand J Work Environ Health. 1983;9:15-24.
17. Orbaek P, Rosen I, Svensson K. Electroneurographic findings in patients with solvent induced central nervous system dysfunction. Br J Ind Med. 1988;45:409-414.
18. World Health Organization. Chronic Effects of Organic Solvents on the Central Nervous System and Diagnostic Criteria. Copenhagen: World Health Organization and Nordic Council of Ministers; 1985.
19. Edling C, Ekberg K. Ahlborg Jr G, Alexandersson R. Long term follow up of workers exposed to solvent. Br J Ind Med. 1990;47:75-82.
20. Evans BA. Nerve action potentials. In: Daube JR, ed. Clinical Neurophysiology. Philadelphia: F.A. Davis Co.; 1996:147-156.
21. Daube JR. Compound muscle action potentials. In: Daube JR, ed. Clinical Neurophysiology. Philadelphia: F.A. Davis Co.; 1996:199-234.
22. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetes. Muscle Nerve. 1988;11:21-32.
23. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology. 1995;45: 1115-1121.
24. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329: 977-986.
25. Robinson LR, Micklesen BS, Wang L. Strategies for analyzing nerve conduction data: superiority of a summary index over single tests. Muscle Nerve. 1998;21: 1166-1171.
26. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neural. 1995;38:869-880.
27. O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology. 1995; 45:17-23.
28. Stetson DS, Albers JW, Silverstein BA, Wolfe RA. Effects of age, sex, and anthropometric factors on nerve conduction measures. Muscle Nerve. 1992;15:1095-1104.
29. Albers JW, Cavender GF, Levine SP, Langolf GD. Asymptomatic sensorimotor polyneuropathy in workers exposed to elemental mercury. Neurology. 1982;32: 1168-1174.
30. Greene DA, Sima AAF, Albers JW, Pfeifer MA. Diabetic neuropathy. In: Rifkin H, Porte D Jr, eds. Ellenberg and Rtfkin's Diabetes Mellitus: Theory and Practice. New York: Elsevier; 1990: 710-755.
31. Letz R, Gerr F. Covariates of human peripheral nerve function: I - nerve conduction velocity and amplitude. Neurotoxicol Teratol. 1994;16:95-104.
32. Stetson DS, Silverstein BA, Keyserling WM, Wolfe RA, Albers JW. Median sensory distal amplitude and latency: comparisons between nonexposed managerial/ professional employees and industrial workers. Am J Ind Med. 1993;24:175-189.
33. Werner RA, Franzblau A. Hand dominance effect on median and ulnar sensory evoked amplitude and latency in asymptomatic workers. Arch Phys Med Rehabil. 1996;77:473-476.
34. Franzblau A, Werner RA, Valle J, Johnston E. Workplace surveillance for carpal tunnel syndrome: a comparison of methods. J Occup Rehabil. 1993;3:1-14.
35. Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. N Engl J Med. 1978;299:690-694.
36. O'Brien PC, Shampo MA. Statistical considerations for performing multiple tests in a single experiment: 2 - comparisons among several therapies. Mayo Clin Proc. 1988;63:816-820.
37. Bromberg MB, Albers JW. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders. Muscle Nerve. 1993;16: 262-266.
38. Werner RA, Albers JW, Franzblau A, Armstrong TJ. The relationship between body mass index and the diagnosis of carpal tunnel syndrome. Muscle Nerve. 1994;17:632-636.
39. Stetson DS. Median and Ulnar Conduction Measures in Control and Industrial Populations: Associations with Ergonomie Risk Factors [doctoral thesis]. Ann Arbor: University of Michigan; 1991:1-251.
40. Rivner MH, Swift TR, Crout BO, Rhodes KP. Toward more rational nerve conduction interpretations: the effect of height. Muscle Nerve. 1990;13:232-239.
41. Albers JW, Brown MB, Sima AAF, Greene DA, for the Tolrestat Study Group for the Early Diabetic Intervention Trial. Nerve conduction measures in mild diabetic neuropathy: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Neurology. 1996;46:85-91.
42. Frumkin H, Ducatman A, Kirkland K. Solvent exposure in the railroad industry (letter). J Occup Environ Med. 1997;39: 926-930.
43. Allen N, Mendell JR, Billmaier DJ, Fontaine RE, O'Neill J. Toxic polyneuropathy due to methyl n-butyl ketone: an industrial outbreak. Arch Neurol. 1975;32:209-218.